BIOARCTIC AB SER'B'NPVBIOARCTIC AB SER'B'NPVBIOARCTIC AB SER'B'NPV

BIOARCTIC AB SER'B'NPV

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−0.84SEK
Revenue estimate
‪18.20 M‬SEK
Market capitalization
‪17.39 B‬SEK
‪229.25 M‬SEK
‪616.00 M‬SEK
‪35.74 M‬
Beta (1Y)
0.72

About BIOARCTIC AB SER. B

CEO
Gunilla Christina Osswald
Headquarters
Stockholm
Employees (FY)
88
Founded
2000
ISIN
SE0010323311
FIGI
BBG00NRVWQ53
BioArctic AB engages in the research and development of modifying treatments and diagnostics for neurodegenerative diseases. Its research areas are Alzheimer’s disease and Parkinson’s disease where there are large unmet medical needs. The company was founded by Lars Gunnar Lannfelt and Pär Lars Gellerfors on January 24, 2003 and is headquartered in Stockholm, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0RV2 is 197.0 SEK — it has increased by 1.89% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange BIOARCTIC AB SER'B'NPV stocks are traded under the ticker 0RV2.
BIOARCTIC AB SER'B'NPV is going to release the next earnings report on May 17, 2024. Keep track of upcoming events with our Earnings Calendar.
0RV2 stock is 2.39% volatile and has beta coefficient of 0.72. Check out the list of the most volatile stocks — is BIOARCTIC AB SER'B'NPV there?
0RV2 earnings for the last quarter are 1.42 SEK per share, whereas the estimation was 0.20 SEK resulting in a 610.00% surprise. The estimated earnings for the next quarter are −0.79 SEK per share. See more details about BIOARCTIC AB SER'B'NPV earnings.
BIOARCTIC AB SER'B'NPV revenue for the last quarter amounts to ‪209.05 M‬ SEK despite the estimated figure of ‪119.00 M‬ SEK. In the next quarter revenue is expected to reach ‪15.90 M‬ SEK.
Yes, you can track BIOARCTIC AB SER'B'NPV financials in yearly and quarterly reports right on TradingView.
0RV2 stock has risen by 2.66% compared to the previous week, the month change is a 10.62% fall, over the last year BIOARCTIC AB SER'B'NPV has showed a 18.60% decrease.
0RV2 net income for the last quarter is ‪−87.24 M‬ SEK, while the quarter before that showed ‪124.95 M‬ SEK of net income which accounts for −169.82% change. Track more BIOARCTIC AB SER'B'NPV financial stats to get the full picture.
Today BIOARCTIC AB SER'B'NPV has the market capitalization of ‪17.39 B‬, it has decreased by 9.42% over the last week.
Like other stocks, 0RV2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOARCTIC AB SER'B'NPV stock right from TradingView charts — choose your broker and connect to your account.
0RV2 reached its all-time high on Jun 12, 2023 with the price of 391.0 SEK, and its all-time low was 25.9 SEK and was reached on Oct 20, 2017.
See other stocks reaching their highest and lowest prices.
As of Apr 28, 2024, the company has 88.00 employees. See our rating of the largest employees — is BIOARCTIC AB SER'B'NPV on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOARCTIC AB SER'B'NPV technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOARCTIC AB SER'B'NPV stock shows the sell signal. See more of BIOARCTIC AB SER'B'NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BIOARCTIC AB SER'B'NPV future price: according to them, 0RV2 price has a max estimate of 450.00 SEK and a min estimate of 336.00 SEK. Read a more detailed BIOARCTIC AB SER'B'NPV forecast: see what analysts think of BIOARCTIC AB SER'B'NPV and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOARCTIC AB SER'B'NPV EBITDA is ‪275.12 M‬ SEK, and current EBITDA margin is 44.66%. See more stats in BIOARCTIC AB SER'B'NPV financial statements.